SAM— AI Stock Forecast & Price Targets
Published 6/19/2026 · A free sample of K3vl4r’s AI-powered analysis.
Kronos price forecasts, scored fundamentals & technicals, and a multi-horizon plan.
View the live SAM price forecast →
Boston Beer is a deteriorating consumer defensive name with a broken topline (-4.69% TTM sales), a brutal Q1 2026 net loss of $145M driven by the Ardagh litigation charge, and a stock down 26% in the quarter and 82% over 5 years. While the Kronos forecasts lean bullish from current $176 levels toward $200-210 and analyst targets sit at $233, the technical structure remains in a clear downtrend and fundamentals are inflecting the wrong way — this is a contrarian HOLD with selective trading interest, not an investable compounder.
1-4 weeks: Tactical long bias from $171-176 toward Kronos's $199-202 forecast zone, supported by oversold RSI 39.5 and the 20% short float that could squeeze. Size small (1-2% position). Hard stop below $158 (52w low) — a break there invalidates the bounce thesis and likely opens $145. Take profits in the $198-208 zone where the forecast lines and SMA50 converge.
1-6 months: HOLD/neutral. The base case is range-bound $170-220 as the market digests the Ardagh appeal timeline and watches whether Sun Cruiser/Twisted Tea can offset Truly category decline. Key catalysts: Q2'26 earnings (sales Q/Q -4.4% trend needs to stabilize), Ardagh appeal progress, summer RTD season sell-through data. Expected return range -10% to +25%. Thesis changes if: gross margin re-expands above 50% (Q1 was 49.3%, decent), or if Truly stabilizes — would upgrade to ACCUMULATE.
1-3 years: Structural skeptic. Hard seltzer category is in secular decline, Twisted Tea is mature, and Sun Cruiser/Dogfish cocktails are interesting but in a hyper-competitive RTD spirits space against Gallo, Diageo, and dozens of startups. The Kronos weekly forecast suggesting $290+ by mid-2027 is plausible only if RTD pivot succeeds. Biggest structural risk: brand portfolio relevance erosion in a category that is fragmenting faster than SAM can innovate. Without a dividend, the long-term case rests entirely on EPS recovery to the $11+ forward estimate — execution risk is high.
The fundamentals show a company in clear cyclical and structural deterioration. TTM revenue of $1.945B is down 4.69% Y/Y, and the quarterly progression is ugly: Q2'25 $588M → Q3'25 $537M → Q4'25 $386M → Q1'26 $434M. Operating margin collapsed from 14.8% in Q2'25 to -8.4% in Q4'25, then snapped back to 5.0% in Q1'26 — but Q1'26 net income was -$145M due to the Ardagh litigation charge ($191M pre-tax combined, partially offset by the $21M interest reversal noted in the June 14 news). Trailing EPS is -$6.14 and ROE -7.75%. The balance sheet is still respectable on a net basis — $164M cash vs only $35M debt, debt/equity 0.05 — but stockholders' equity dropped from $846M (Dec'25) to $683M (Mar'26), and current ratio of 0.93 with negative working capital of -$31M signals tightening liquidity. Free cash flow TTM of $371M is the bright spot and supports the 9.4x P/FCF multiple, but Q1'26 FCF was -$33M, so the run-rate is weakening. Capital allocation: no dividend, and high insider ownership (27.4%) is a double-edged sword. Forward P/E of 15.7x and PEG of 2.44 are not cheap given a 6.4% LT EPS growth estimate and contracting sales.
Across timeframes the picture is bearish-to-neutral with a possible mean-reversion setup. The 1h chart shows price recovered from the June low near $160 to ~$176, but Kronos forecasts a continued grind higher into $200-220 with a central forecast of $199. The 4h chart contextualizes this: SAM topped near $264 in April, broke down through May (the -26% quarter performance), and has only just stabilized — Kronos sees a bounce toward $202 but the high/low band is wide. The 1d view shows the same: clear downtrend with lower highs from $260, and the forecast is sideways-to-down at $203. The weekly forecast extends to 2028 and is striking — it projects a multi-year range of ~$180-$400 with a central path peaking near $400 in mid-2027 before fading to ~$290. Current price $176 is -35% from 52w high, -19.4% below SMA200, -15.3% below SMA50, and RSI 39.5 — oversold but not capitulation. Short interest at 20.17% of float / short ratio 6.06 is very high and creates squeeze potential. Key support: $158-160 (52w low); resistance: $200 (Kronos forecast, SMA50 zone) then $220-230.
The dominant signal in the news is the Ardagh supplier litigation: the April/May 2026 jury verdict and amended judgement resulted in a $191M pre-tax charge partially offset by a $21M interest reversal — this is what produced the -$145M Q1'26 net loss and is the proximate cause of the share weakness (Simply Wall St / Yahoo, June 14). Boston Beer is appealing. Morgan Stanley cut its price target on May 7 citing rising costs and macro pressure (Insider Monkey, May 21), and StockStory flagged SAM among names where Wall Street price targets may be too optimistic (May 27). The rest is brand/marketing noise that signals management is leaning into the higher-margin RTD/cocktail category — Dogfish Head 'Secret Stash Cooler' (June 17) and Sun Cruiser activation at the U.S. Open as official canned cocktail sponsor (June 15). These are incremental positives for the Beyond Beer / Sun Cruiser growth story but won't move the needle near-term against the litigation overhang and category softness.
- Sun Cruiser scaling — U.S. Open Official Canned Cocktail sponsorship (June 15 news) is a meaningful brand investment in the highest-growth RTD subcategory
- Dogfish Head premium cocktail line extensions (Secret Stash Cooler, June 17) leveraging the spirits-based RTD margin profile
- Ardagh litigation appeal — if successful in reducing the $191M judgement, would unlock material EPS revision higher
- Margin recovery: Q1'26 gross margin 49.3% holding near TTM 48.7% suggests cost programs are working despite the topline decline
- Forward EPS of $11.09 vs trailing -$6.14 implies analysts expect normalized earnings to return — successful execution drives multiple re-rating
- Ardagh judgement: $191M pre-tax charge already booked; an unfavorable appeal outcome locks in the loss and could stress the balance sheet (equity already fell $164M Q/Q)
- Hard seltzer secular decline — Truly category contraction is structural, not cyclical
- Sales Q/Q -4.4% and Sales Y/Y TTM -4.7% show no topline inflection yet
- Current ratio 0.93 and negative working capital -$31M indicate tighter liquidity than the headline cash balance suggests
- 20.17% short float is double-edged: signals bearish institutional view and elevated borrow costs
- Forward P/E 15.7x and PEG 2.44 leave little valuation cushion if EPS recovery disappoints
- Morgan Stanley PT cut (May 7) and StockStory skepticism suggest sell-side de-rating is ongoing
- Consumer Defensive sector facing input cost pressure and trade-down behavior in beverages
- No dividend — investors are paid only via capital appreciation, raising the bar for the equity story
Get AI analysis on any stock
This is one of hundreds of Kronos AI reports — scored fundamentals & technicals, bull/base/bear price targets, a multi-horizon plan, and continuously-updated forecasts across the market. Create a free account to explore them all.
Create your free account →Already a member? Sign in · Join our Discord